Biostimulators
PRP for Hair Loss Adds Density, Not Thickness. The Size of the Gain Is Still Uncertain.

In Greta Gerwig's 2019 film of Little Women, Jo March cuts off her long hair and sells it to pay for her mother's journey to her wounded father. The film does not treat the sacrifice as vanity. The hair is worth something, and everyone in the room can see exactly what it cost.

Patients with thinning hair do a quieter version of the same arithmetic. They count what is left, and many ask me whether platelet-rich plasma (PRP) for hair loss can give some of it back. PRP is made from a patient's own blood and injected into the scalp.
My argument is that the pooled trials point to a gain in hair density, no clear gain in hair thickness, and no confident estimate of how large the density gain is. Five papers carry the case: a 2024 systematic review in the Journal of Cosmetic Dermatology, two further meta-analyses (2024 and 2025), a meta-analysis in women (2023), and a 2020 randomized trial in women. I read the full text of one of them, the 2025 meta-analysis, and the abstracts of the other four, so what follows about those four is limited to what their abstracts report.
What does PRP for androgenetic alopecia actually claim to do?
PRP is an injection of your own concentrated platelets into the scalp, tested mainly in androgenetic alopecia, the common pattern of gradual hair thinning. The claim worth testing is simple: that after a course of injections, there is more hair per square centimeter than there would have been without them.
That is a countable outcome, which is why the trials report hair density, measured in hairs per square centimeter (hairs/cm²), and hair thickness, usually reported as hair diameter or caliber. The two can move separately, and the evidence below shows that they do.
Does platelet-rich plasma increase hair density?
On average, yes, in pooled trials, but the size of the gain depends on which review you read. A 2024 meta-analysis of randomized trials in androgenetic alopecia (14 studies, 431 patients, 13 pooled) found PRP associated with an increase of about 27.55 hairs/cm² compared with placebo (Kieling et al., 2024). The confidence interval ran from 14.04 to 41.06, and heterogeneity (how much the studies disagree with one another) was very high, with an I² of 95.99% (Kieling et al., 2024). The authors graded the certainty of the evidence as low.
A larger 2025 meta-analysis of 43 randomized trials, 41 of them pooled, with 1,877 participants, found a smaller overall gain: a mean difference of 19.6 hairs/cm² (95% CI 6.4 to 32.8; 24 studies, 1,198 participants), with an I² of 93.5% (Anitua et al., 2025). Against placebo alone the estimate was 28.4 hairs/cm² (95% CI 12.8 to 44.0; 18 studies, 883 participants) (Anitua et al., 2025).
A third review, in the Journal of Cosmetic Dermatology, looked only at male androgenetic alopecia. It included eight randomized trials and one cohort study (291 participants). Six studies reported a significant increase in hair density with PRP compared with control, and five reported a significant increase in hair count (Donnelly et al., 2024). The authors concluded that PRP showed some therapeutic potential, while the low quality of evidence, moderate risk of bias, and high heterogeneity limited firm conclusions (Donnelly et al., 2024).
The direction is consistent. The numbers are not.
Does PRP make individual hairs thicker?
Not reliably. In the 2024 meta-analysis, the effect on hair diameter was 2.02 micrometers (95% CI −0.85 to 4.88), which includes zero, and the certainty of the evidence was graded very low (Kieling et al., 2024). The 2025 meta-analysis found the same pattern for hair thickness: a mean difference of 8.2 (95% CI −4.3 to 20.7), not statistically significant (Anitua et al., 2025).
One small trial did report a thickness change. In 30 women, hair caliber rose by 0.0053 mm in the PRP group and fell by 0.0060 mm in the placebo group at week 24 (P < .01) (Dubin et al., 2020). A single trial with 30 people does not outweigh pooled estimates from dozens, but it is a reminder that the thickness question is not closed.
The practical point is that density and thickness are different promises. A treatment that adds more hairs per square centimeter has not necessarily made each hair thicker.
Does PRP work for women with female pattern hair loss?
The evidence is encouraging but thinner, and the strongest single trial was industry supported. A meta-analysis of seven articles on women with androgenetic alopecia reported a standardized mean difference of 2.98 for terminal hair density (95% CI 1.10 to 4.85), and no significant increase in hair thickness (SMD 1.16; 95% CI −0.96 to 3.28). No major side effects were reported (Oliveira et al., 2023).
A randomized trial of 30 women compared PRP with saline injections given at weeks 0, 4 and 8. At week 24, hair density had changed by +105.9 hairs/cm² in the PRP group and −52.4 hairs/cm² in the placebo group (P < .01), and 57% of PRP patients improved on blinded photographic assessment compared with 7% of the saline group (Dubin et al., 2020). Two patients were lost to follow-up, and the study was supported by the manufacturer of the PRP system used (Dubin et al., 2020).
That is a promising result with an obvious caveat. A single sponsored trial in 30 women cannot settle the question, and the 2024 meta-analysis found only two female-only studies with usable data for its subgroup analysis (Kieling et al., 2024).
Does the way PRP is prepared change the result?
It may, but the comparisons are indirect. In the 2025 meta-analysis, activated PRP (PRP treated to trigger platelets to release their contents) was associated with a gain of 23.6 hairs/cm² (95% CI 8.7 to 38.4; 11 studies, 554 participants), while non-activated PRP was not significant (18.3 hairs/cm²; 95% CI −6.5 to 43.0) (Anitua et al., 2025). The authors could analyze little beyond activation status because the studies reported PRP composition, including white blood cell content, poorly (Anitua et al., 2025).
PRP compared directly with minoxidil, a standard topical hair treatment, gave a mean difference of −22.9 hairs/cm² (95% CI −50.8 to 5.0), which was not statistically significant (Anitua et al., 2025). A wide interval that crosses zero does not show that the two are equal. It shows that the trials cannot tell.
Is PRP for hair loss safe?
The reported adverse events were mild and short-lived. In the 2025 meta-analysis, adverse events did not differ significantly from controls overall (OR 1.7; 95% CI 0.77 to 3.7), and the events described were mostly injection pain, redness, swelling and bruising (Anitua et al., 2025). The women's trial listed headache, scalp tightness, swelling, redness and bleeding after injection (Dubin et al., 2020).
The trials were small and short, mostly three to six months, so they cannot rule out rarer or later problems (Anitua et al., 2025).
The strongest objection
Some will say the pooled results settle it. Several reviews point the same way, and the two largest report statistically significant gains in hair density. That is partly true. The direction of the effect is consistent across reviews (Anitua et al., 2025; Donnelly et al., 2024; Kieling et al., 2024).
But heterogeneity was above 93% in the pooled analyses, the trials were small, and the reviews graded the quality of evidence differently: low certainty for hair density in one (Kieling et al., 2024) and moderate in the authors' own judgment in another (Anitua et al., 2025). Several trials treated one half of the scalp and compared it with the other, a design that the 2024 authors warn may let PRP spread into the placebo area and confound results (Kieling et al., 2024). Most trials were unblinded or used subjective outcomes, and only one addressed a cause of hair loss other than pattern thinning (Anitua et al., 2025). Two authors of the 2025 review are affiliated with a PRP-focused institute, which readers may wish to weigh (Anitua et al., 2025).
The Clinical Bottom Line
PRP is a reasonable option to discuss for pattern hair loss, as long as the conversation is about hair density and not a transformation. Pooled trials favor PRP over placebo for hair density, with estimates between roughly 20 and 28 hairs/cm² depending on the review (Anitua et al., 2025; Kieling et al., 2024), and reported side effects were mild. Hair thickness did not improve significantly in the pooled analyses (Anitua et al., 2025; Kieling et al., 2024; Oliveira et al., 2023).
The questions to bring to a consultation follow from the gaps. Ask what type of hair loss you have, because almost all of the evidence is in androgenetic alopecia. Ask how the PRP is prepared and whether it is activated, because the studies do not standardize it. And ask how results will be measured, because a photograph and a hair count are not the same claim.
Jo March knew what her hair was worth, because someone counted it out in front of her. The trials are still deciding what ours is.
For clinical assessments and consultation in Seoul: itsdrbock.com
Cover image: Illustration from the first edition of Little Women, May Alcott (1868). Public domain. Source: Wikimedia Commons
References
Anitua, E., Tierno, R., & Alkhraisat, M. H. (2025). Platelet-rich plasma in the management of alopecia: A systematic review and meta-analysis of clinical evidence. Dermatology and Therapy, 15(11), 3213–3252. https://doi.org/10.1007/s13555-025-01542-8
Donnelly, C., Minty, I., Dsouza, A., Wong, Y. Y., Mukhopadhyay, I., Nagarajan, V., Rupra, R., Charles, W. N., & Khajuria, A. (2024). The role of platelet-rich plasma in androgenetic alopecia: A systematic review. Journal of Cosmetic Dermatology, 23(5), 1551–1559. https://doi.org/10.1111/jocd.16185
Dubin, D. P., Lin, M. J., Leight, H. M., Farberg, A. S., Torbeck, R. L., Burton, W. B., & Khorasani, H. (2020). The effect of platelet-rich plasma on female androgenetic alopecia: A randomized controlled trial. Journal of the American Academy of Dermatology, 83(5), 1294–1297. https://doi.org/10.1016/j.jaad.2020.06.1021
Kieling, L., Konzen, A. T., Zanella, R. K., & Valente, D. S. (2024). Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials. Anais Brasileiros de Dermatologia, 99(6), 847–862. https://doi.org/10.1016/j.abd.2024.01.002
Oliveira, A. F. Q. de, Arcanjo, F. P. N., Rodrigues, M. R. P., Rosa e Silva, A. A., & Hall, P. R. (2023). Use of autologous platelet-rich plasma in androgenetic alopecia in women: A systematic review and meta-analysis. Journal of Dermatological Treatment, 34(1), Article 2138692. https://doi.org/10.1080/09546634.2022.2138692
More From the Blog

Hand Rejuvenation Is Two Problems, Not One. The Evidence for Every Fix Is Still Small.

Chemical Peels for Acne Work About Equally Well. The Real Choice Is How Your Skin Tolerates the Acid.
